Ramipril labels and packages: Difference between revisions

Revision as of 17:57, 18 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

For patient information about Ramipril, click here.

Ramipril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

Adapted from the FDA Package Insert.

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AM}}
-<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher =  | date =  | accessdate = }}</ref>
+{|
+| [[File:cc9.png|800px|thumb]]
+|}
+{|
+| [[File:c10.png|800px|thumb]]
+|}
+{|
+| [[File:c11.png|800px|thumb]]
+|}
+{|
+| [[File:c12.png|800px|thumb]]
+|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher =  | date =  | accessdate = }}</ref>